SCHEMBL26928554

SCHEMBL26928554

O=C(NCC1CC1)c1ccc2cnccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 2/20 0.58
HDAC3 O15379 2/20 0.57
HDAC1 Q13547 2/20 0.57
HDAC2 Q92769 2/20 0.57
HDAC4 P56524 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC9 Q9UKV0 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
NAMPT P43490 3/20 0.54
ROCK2 O75116 2/20 0.52
BCHE P06276 1/20 0.50
MAOB P27338 1/20 0.50
AKT1 P31749 6/20 0.49
CDK2 P24941 3/20 0.49
MAPK14 Q16539 1/20 0.49
PRMT3 O60678 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21900928 0.87 NAMPT (0.59) SMYD3NAMPTAKT1CDK2
SCHEMBL3017757 0.81 HDAC3 (0.71) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL28148124 0.79 SMYD3 (0.87) SMYD3AKT1CDK2MAPK14PRMT3
SCHEMBL1519811 0.78 SMYD3 (0.60) SMYD3HDAC3HDAC1HDAC2NAMPT
SCHEMBL28437816 0.76 SMYD3 (0.58) SMYD3HDAC3HDAC1HDAC2HDAC8
SCHEMBL30824367 0.76 HDAC3 (0.57) SMYD3HDAC3HDAC1HDAC2NAMPT
SCHEMBL21900830 0.76 NAMPT (0.71) HDAC3HDAC1HDAC2HDAC4HDAC7
SCHEMBL26928711 0.76 HDAC3 (0.57) SMYD3HDAC3HDAC1HDAC2NAMPT
SCHEMBL22583343 0.76 THRB (0.64) HDAC1HDAC6
SCHEMBL17643849 0.75 SMYD3 (0.57) SMYD3HDAC3HDAC1HDAC2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239729-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS XENON PHARMACEUTICALS INC. (CA) 2023-12-14 WO claimed
WO-2023239729-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS XENON PHARMACEUTICALS INC. (CA) 2023-12-14 WO disclosed